TickerFacts.

Electromedical Technologies, Inc (EMED): Cost of Revenue

Annual figures by period end, from SEC filings.

Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

$303.3K
Year ended 2023-12-31
+16.0%
3-year compound annual growth
2019-12-31: $238.5K2020-12-31: $194.4K2021-12-31: $199.2K2022-12-31: $261.2K2023-12-31: $303.3K$303.3K
2019-12-31 Cost of Revenue (USD) 2023-12-31
Period endedCost of RevenueChange YoYSource filing
2023-12-31$303.3K+16.1%2024-05-01, From 2023-01-01
2022-12-31$261.2K+31.1%2024-05-01, From 2022-01-01
2021-12-31$199.2K+2.5%2023-03-31, From 2021-01-01
2020-12-31$194.4K-18.5%2022-03-31, From 2020-01-01
2019-12-31$238.5Kn/a2021-03-30, From 2019-01-01